title: Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP).
abstract: Lymphatic invasion (LI) identified by immunohistochemical (IHC) staining is common in primary cutaneous melanoma, and LI has been shown to be an independent prognostic factor in melanoma. Its prognostic significance in melanocytic tumors of uncertain malignant potential (MELTUMPs) has not been well characterized. This study included 32 patients with provisional diagnoses of MELTUMP. Lesions were evaluated for tumor thickness, the presence of ulceration, mitotic figures, mitotic figures at the base, tumor infiltrating lymphocytes, as well as peritumoral and intratumoral lymphatic density. Dual IHC staining was used to microscopically detect lymphatic endothelium (podoplanin) containing melanoma cells (S100), with the aid of multispectral imaging in select cases. Univariate analysis was performed to identify associations between clinical and pathologic variables and melanoma-related events. The 32 patients had a median follow-up of 111 months. Two patients subsequently died of melanoma-related disease, 1 died of unknown causes, 5 developed nodal metastases, and the remainder showed no evidence of progressive disease. LI was identified in 8/32 patients (25%) by dual IHC staining, which included the 2 patients who died of melanoma-related disease, 1 patient with bulky nodal metastasis, 1/4 patients with microscopic nodal metastases, and 4 patients who showed no evidence of progressive disease. The presence of LI was associated with melanoma metastases or melanoma-related death (P=0.05). The presence of LI by dual IHC in MELTUMPs is associated with a poorer prognosis, specifically with melanoma metastasis, and may therefore serve as a useful prognostic factor for risk stratification of patients with these diagnostically challenging lesions.
authors.affiliation: Department of Pathology, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104, USA.
authors.forename: Ronnie M
authors.initials: RM
authors.lastname: Abraham
authors.forename: Giorgos
authors.initials: G
authors.lastname: Karakousis
authors.forename: Geza
authors.initials: G
authors.lastname: Acs
authors.forename: Amy F
authors.initials: AF
authors.lastname: Ziober
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Cerroni
authors.forename: Martin C
authors.initials: MC
authors.lastname: Mihm
authors.forename: David E
authors.initials: DE
authors.lastname: Elder
authors.forename: Xiaowei
authors.initials: X
authors.lastname: Xu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis / Q000473:pathology*; D008297:Male; D008545:Melanoma / Q000473:pathology*; D008875:Middle Aged; D009508:Nevus, Pigmented / Q000473:pathology*; D012878:Skin Neoplasms / Q000473:pathology*; D055815:Young Adult
references.citation: Pathology. 2004 Oct;36(5):428-34
references.pmid: 15370112
references.citation: N Engl J Med. 2006 Sep 28;355(13):1307-17
references.pmid: 17005948
references.citation: Hum Pathol. 1999 May;30(5):513-20
references.pmid: 10333219
references.citation: Semin Diagn Pathol. 1998 Aug;15(3):189-94
references.pmid: 9711668
references.citation: Clin Lab Med. 2000 Dec;20(4):745-58
references.pmid: 11221513
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3622-34
references.pmid: 11504744
references.citation: Am J Surg Pathol. 2009 Sep;33(9):1386-95
references.pmid: 19609204
references.citation: J Am Acad Dermatol. 2010 Mar;62(3):469-79
references.pmid: 20159313
references.citation: Adv Dermatol. 1997;13:289-304
references.pmid: 9551147
references.citation: Am J Surg Pathol. 2010 Mar;34(3):314-26
references.pmid: 20118771
references.citation: Cancer. 2009 Feb 1;115(3):631-41
references.pmid: 19123453
references.citation: Am J Pathol. 2003 Jun;162(6):1951-60
references.pmid: 12759251
references.citation: Clin Cancer Res. 2012 Jan 1;18(1):229-37
references.pmid: 22096024
references.citation: J Clin Pathol. 2006 Feb;59(2):166-73
references.pmid: 16443733
references.citation: J Cutan Pathol. 2009 Jul;36(7):772-80
references.pmid: 19032379
references.citation: Am J Surg Pathol. 2002 Jan;26(1):47-55
references.pmid: 11756768
references.citation: Hum Pathol. 2008 Jun;39(6):901-9
references.pmid: 18440591
references.citation: Ann Surg Oncol. 2008 Jan;15(1):302-9
references.pmid: 18000712
references.citation: Melanoma Res. 1997 Feb;7(1):63-8
references.pmid: 9067967
references.citation: Monogr Pathol. 1988;(30):110-52
references.pmid: 3050461
references.citation: Am J Clin Pathol. 2004 Jun;121 Suppl:S3-32
references.pmid: 15298148
references.citation: Am J Surg Pathol. 2008 Jan;32(1):36-44
references.pmid: 18162768
references.citation: J Cutan Pathol. 2010 Apr;37 Suppl 1:54-9
references.pmid: 20482676
references.citation: Am J Surg Pathol. 2011 Feb;35(2):235-42
references.pmid: 21263244
references.citation: Am J Dermatopathol. 2004 Aug;26(4):310-33
references.pmid: 15249862